Cellyan Biotechnology Co. Ltd (HKPD) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-12
1:08 pm
Purchase
2025-10-0613DCELLYAN BIOTECHNOLOGY CO LTD
HKPD
Wang Liying7,150,000
65.000%
7,150,000increase
(New Position)
Filing
History
2025-06-05
12:19 pm
Purchase
2025-03-3113GCELLYAN BIOTECHNOLOGY CO LTD
HKPD
Atlantic Health Century International Group617,850
5.620%
617,850increase
(New Position)
Filing
History
2025-06-05
12:18 pm
Purchase
2025-03-3113GCELLYAN BIOTECHNOLOGY CO LTD
HKPD
Pacific Health Century International Group617,850
5.620%
617,850increase
(New Position)
Filing
History
2025-06-03
10:00 am
Purchase
2025-03-3113GCELLYAN BIOTECHNOLOGY CO LTD
HKPD
Wong Lap Sun6,244,961
56.770%
6,244,961increase
(New Position)
Filing
History